Poolbeg Pharma PLC
POLB.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -£5,944 | -£3,931 | -£4,777 | -£2,336 |
| Dep. & Amort. | £114 | £26 | £26 | £18 |
| Deferred Tax | £0 | £0 | £91 | -£782 |
| Stock-Based Comp. | £621 | £0 | £429 | £240 |
| Change in WC | £135 | £0 | £72 | -£68 |
| Other Non-Cash | £428 | -£476 | -£209 | £782 |
| Operating Cash Flow | -£4,646 | -£3,847 | -£4,368 | -£2,146 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -£129 | £0 | -£597 | -£81 |
| Net Acquisitions | £0 | £0 | £0 | £0 |
| Inv. Purchases | £0 | £0 | £0 | £0 |
| Inv. Sales/Matur. | £0 | £0 | £0 | £0 |
| Other Inv. Act. | £428 | £359 | £209 | £0 |
| Investing Cash Flow | £299 | £359 | -£388 | -£81 |
| Financing Activities | – | – | – | – |
| Debt Repay. | £0 | £0 | £0 | £0 |
| Stock Issued | £0 | £0 | £0 | £23,176 |
| Stock Repurch. | £0 | £0 | £0 | £0 |
| Dividends Paid | £0 | £0 | £0 | £0 |
| Other Fin. Act. | £0 | £0 | £0 | £0 |
| Financing Cash Flow | £0 | £0 | £0 | £23,176 |
| Forex Effect | £0 | £0 | £0 | £0 |
| Net Chg. in Cash | -£4,347 | -£4,022 | -£4,756 | £20,949 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | £12,171 | £16,193 | £20,949 | £0 |
| End Cash | £7,824 | £12,171 | £16,193 | £20,949 |
| Free Cash Flow | -£4,775 | -£4,022 | -£4,965 | -£2,227 |